Skip to main content

Table 3 Impact of different prognostic variables on survival outcome

From: Relapsed Wilms’ tumor in pediatric patients: challenges in low- to middle-income countries—a single-center experience

Variables

No. of patients

Event-free survival at 60 months (5 years)

P

Overall survival at 60 months (5 years)

P

Total

30

29.8

 

30.9

 

Age

 <5 years

20

38.2

0.091

38.5

0.146

 ≥5 years

10

NA

 

NA

Gender

 Male

18

29.6

0.864

30.0

0.984

 Female

12

30.9

 

34.7

Interval between diagnosis and relapse

 ≤12 months

13

44.9

 

44.9

0.478

 >12 months

17

16.8

0.685

18.4

Interval between nephrectomy and relapse

 <12 months

13

44.9

0.685

44.9

0.478

 > = 12 months

17

16.8

 

18.4

No. of adverse prognostic factors

 1 and 2

15

19.3

0.920

21.1

0.821

 3,4, and 5

15

38.9

 

38.9

 

Initial metastatic status

 No

22

37.8

0.129

37.8

0.145

 Yes

8

NA

 

NA

Initial pathology

 Favorable

24

30.3

0.647

31.5

0.681

 Unfavorable

6

NA

 

NA

Initial systemic stage

 I, II

10

45.0

0.565

45.0

0.511

 III

12

28.1

 

28.1

 IV

8

NA

 

NA

Initial local stage

 I

7

47.6%

NA

47.6

NA

 II

4

25.0

NA

25.0

 III

19

21.8

NA

24.2

Site of relapse

 Local

11

12.5

0.934

12.5

0.787

 Distant

10

33.3

 

40.0

 Combined

9

44.4

 

44.4

RTH in relapse**

 No

12

11.1

0.013

16.7

0.012

 Yes

18

41.9

 

41.9

Risk stratification

 Standard

10

57.1

0.029

57.1

0.035

 High/very High

20

15

 

17

Post-operative residual

 No

24

30.9

0.957

32.3

0.944

 Yes

5

25.0

 

25.0

  1. ** RTH radiotherapy